Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.25
Delayed Data
As of Nov 17
 +0.05 / +0.81%
Today’s Change
3.30
Today|||52-Week Range
6.70
+14.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$179.3M

Company Description

CytoSorbents Corp. engages in the development blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product, CytoSorb, is a extracorporeal cytokine filter and seeks to reduce cytokine storm that could otherwise cause massive inflammation, organ failure, and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885825

Employees

Shareholders

Other institutional5.02%
Mutual fund holders3.61%
Individual stakeholders24.17%

Top Executives

Phillip P. ChanPresident Chief Executive Officer & Director
Vincent J. CapponiChief Operating Officer
Kathleen P. BlochCFO, Secretary & Principal Accounting Officer
Steven SiskDirector-Clinical Operations
Eric G. MortsensonChief Medical Officer